A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Regulatory actions for Jan. 13, 2026
Regulatory actions for Jan. 13, 2026
Med-tech gainers and losers for Jan. 5-9, 2026
Med-tech gainers and losers for Jan. 5-9, 2026
Financings for Jan. 12, 2026
Financings for Jan. 12, 2026
In the clinic for Jan. 12, 2026
In the clinic for Jan. 12, 2026
Other news to note for Jan. 12, 2026
Other news to note for Jan. 12, 2026
Regulatory actions for Jan. 12, 2026
Regulatory actions for Jan. 12, 2026
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
Biggest gainers and losers for Jan. 5-9, 2026
Biggest gainers and losers for Jan. 5-9, 2026
Tecregen raises seed round to progress thymus-restoring biologics
Tecregen raises seed round to progress thymus-restoring biologics
Monash University describes new melanocortin MC5 receptor agonists
Monash University describes new melanocortin MC5 receptor agonists
New CDK2 degraders disclosed in Triana Biomedicines patent
New CDK2 degraders disclosed in Triana Biomedicines patent
In the clinic for Jan. 9, 2026
In the clinic for Jan. 9, 2026
Other news to note for Jan. 9, 2026
Other news to note for Jan. 9, 2026
Regulatory actions for Jan. 9, 2026
Regulatory actions for Jan. 9, 2026
Money raised by biopharma
Money raised by biopharma
Biopharma money raised: Jan. 1-8, 2026
Biopharma money raised: Jan. 1-8, 2026
Roche divulges new NLRP3 inflammasome inhibitors
Roche divulges new NLRP3 inflammasome inhibitors
Hansoh describes new TNF-α inhibitors for autoimmune diseases
Hansoh describes new TNF-α inhibitors for autoimmune diseases
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page